Genomic Associations of Chemoimmunotherapy Outcomes in a Real-World Cohort of Small Cell Lung Cancer (SCLC) Patients

被引：0
|
作者：
Ullah, A. T. [1 ]
Quintanilha, J. [2 ]
Graf, R. [2 ]
Oxnard, G. [2 ]
Riess, J. W. [1 ]
机构：
[1] UC Davis Comprehens Canc Ctr, Sacramento, CA USA
[2] Fdn Med Inc, Cambridge, MA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Small Cell Lung Cancer; Immune Checkpoint Inhibitors; Genomic Associations;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.13-03
引用
收藏
页码：S367 / S368
页数：2
相关论文
共 50 条
  • [31] Educational level, management and outcomes in small-cell lung cancer (SCLC): A population-based cohort study
    Tendler, Salomon
    Holmqvist, Marit
    Wagenius, Gunnar
    Lewensohn, Rolf
    Lambe, Mats
    De Petris, Luigi
    LUNG CANCER, 2020, 139 : 111 - 117
  • [32] Real-world treatment patterns and outcomes in PD-L1-positive non-small cell lung cancer
    Zhang, Xinke
    DeClue, Richard W.
    Herms, Lisa
    Yang, Mo
    Pawar, Vivek
    Masters, Elizabeth T.
    Ruisi, Mary
    Chin, Kevin
    Velcheti, Vamsidhar
    IMMUNOTHERAPY, 2021, 13 (18) : 1521 - 1533
  • [33] International Consortium Real-World Outcomes in Extensive Disease Small Cell Lung Cancer Compared to IMPOWER133 And CASPIAN
    Khan, S.
    Hueniken, K.
    Brown, C. M.
    Tan, K.
    Wenzlaff, A. S.
    Fernandez-Tardon, G.
    Pesatori, A.
    Barnett, M. J.
    Kothari, J.
    Ma, H.
    Perez-Rios, M.
    Davies, M. P. A.
    Schoettker, B.
    Xie, J.
    Leighl, N. B.
    Tsao, M.
    Zhang, J.
    Brenner, H.
    Andrew, A. S.
    Wang, Y.
    Field, J. K.
    Ruano-Ravina, A.
    Schabath, M. B.
    Shen, H.
    Le Marchand, L.
    Christiani, D. C.
    Neuhouser, M. L.
    Landi, M. T.
    Tardon, A.
    Taylor, F.
    Schwartz, A. G.
    Yang, P.
    Hung, R. J.
    Xu, W.
    Shepherd, F. A.
    Liu, G.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S679 - S679
  • [34] Efficacy and Safety of Anlotinib in the Treatment of Small Cell Lung Cancer: A Real-World Observation Study
    Yuan, Jing
    Cheng, Feng
    Xiao, Guodong
    Wang, Xiaofeng
    Fan, Huijie
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [35] Real-world predictors of survival in patients with limited-stage small-cell lung cancer in Manitoba, Canada
    Dawe, David E.
    Rittberg, Rebekah
    Syed, Iqra
    Shanahan, Mary Kate
    Moldaver, Daniel
    Bucher, Oliver
    Galloway, Katie
    Reynolds, Kayla
    Paul, James T.
    Harlos, Craig
    Kim, Julian O.
    Banerji, Shantanu
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [36] Clinical characteristics and patient outcomes of molecular subtypes of small cell lung cancer (SCLC)
    Ding, Xiao-Long
    Su, Yi-Ge
    Yu, Liang
    Bai, Zhou-Lan
    Bai, Xue-Hong
    Chen, Xiao-Zhen
    Yang, Xia
    Zhao, Ren
    He, Jin-Xi
    Wang, Yan-Yang
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [37] Clinical characteristics and patient outcomes of molecular subtypes of small cell lung cancer (SCLC)
    Xiao-Long Ding
    Yi-Ge Su
    Liang Yu
    Zhou-Lan Bai
    Xue-Hong Bai
    Xiao-Zhen Chen
    Xia Yang
    Ren Zhao
    Jin-Xi He
    Yan-Yang Wang
    World Journal of Surgical Oncology, 20
  • [38] Real-world outcomes of immunotherapy-based regimens in first-line advanced non-small cell lung cancer
    Waterhouse, David
    Lam, Jenny
    Betts, Keith A.
    Yin, Lei
    Gao, Sophie
    Yuan, Yong
    Hartman, John
    Rao, Sumati
    Lubinga, Solomon
    Stenehjem, David
    LUNG CANCER, 2021, 156 : 41 - 49
  • [39] A Comparative Analysis between Real-World Data and Clinical Trials to Evaluate Differences in Outcomes for SCLC Patients
    Marzano, L.
    Dan, A.
    Tendler, S.
    Darwich, A. S.
    Raghothama, J.
    De Petris, L.
    Lewensohn, R.
    Meijer, S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S697 - S697
  • [40] Real-world treatment patterns and survival in extensive stage small-cell lung cancer in Japan
    Horinouchi, Hidehito
    Chang, Chia-Hsien Suzu
    Shaw, Jaime
    Archangelidi, Olga
    Balasubramanian, Akhila
    Pundole, Xerxes
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, : 383 - 390
12345